FINANCIAL INSTRUMENTS (Details Narrative) |
12 Months Ended | |||
|---|---|---|---|---|
|
Dec. 31, 2025
CAD ($)
|
Dec. 31, 2024
CAD ($)
|
Dec. 31, 2025
USD ($)
|
Dec. 31, 2024
USD ($)
|
|
| Disclosure of detailed information about financial instruments [abstract] | ||||
| Impairment loss | ||||
| Surplus | $ 15,171,887 | $ 4,421,006 | ||
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of impairment loss recognised in other comprehensive income. Impairment loss on a revalued asset is recognised in other comprehensive income to the extent that the impairment loss does not exceed the amount in the revaluation surplus for that same asset. [Refer: Impairment loss; Revaluation surplus; Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition A component of equity representing the accumulated revaluation surplus on the revaluation of assets recognised in other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|